2393 — Yestar Healthcare Holdings Co Income Statement
0.000.00%
- HK$193.52m
- HK$480.71m
- CNY2.41bn
- 52
- 99
- 78
- 91
Annual income statement for Yestar Healthcare Holdings Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 4,107 | 4,931 | 2,805 | 2,913 | 2,410 |
Cost of Revenue | |||||
Gross Profit | 807 | 849 | 398 | 513 | 399 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 4,681 | 4,710 | 3,016 | 2,707 | 1,450 |
Operating Profit | -574 | 221 | -212 | 206 | 960 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -693 | 59.9 | -485 | 41 | 930 |
Provision for Income Taxes | |||||
Net Income After Taxes | -645 | 12.7 | -474 | 1.48 | 903 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -590 | 3.33 | -992 | -13.9 | 922 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -590 | 3.33 | -992 | -13.9 | 922 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.037 | 0.003 | -0.163 | -0.011 | 0.009 |